Adalimumab induction therapy for crohn disease previously treated with infliximab : A randomized trial. Commentary
- Author
- SANDBORN, William J; RUTGEERTS, Paul; POLLACK, Paul F; MANNON, Peter (Commentator (written text))
1 ; ENNS, Robert; HANAUER, Stephen B; COLOMBEL, Jean-Frédéric; PANACCIONE, Remo; D'HAENS, Geert; JU LI; ROSENFELD, Marie R; KENT, Jeffrey D
[1] National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, United States
[2] Mayo Clinic, Rochester, Minnesota, United States
[3] Universitaire Ziekenhuizen Leuven and Gasthuisberg, Leuven, Belgium
[4] University of British Columbia, Vancouver, British Columbia, Canada
[5] University of Chicago, Chicago, Illinois, United States
[6] Hôpital Claude Huriez and Centre Hospitalier et Universitaire de Lille, Lille, France
[7] University of Calgary, Calgary, Alberta, Canada
[8] Imelda General Hospital, Bonheiden, Belgium
[9] Abbott Laboratories, Parsippany, New Jersey, United States - Source
Annals of internal medicine. 2007, Vol 146, Num 12 ; 829-838, 888-890 [13 p.] ; ref : 29 ref
- CODEN
- AIMEAS
- ISSN
- 0003-4819
- Scientific domain
- General medicine general surgery
- Publisher
- American College of Physicians, Philadelphia, PA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Adalimumab Antipsoriasique Antirhumatismal Chimiothérapie Entérite de Crohn Essai clinique Homme Immunodépresseur Immunomodulateur Infliximab Médecine Randomisation Traitement Anti-TNF-alpha Anticorps monoclonal Anticytokine Cytokine Facteur nécrose tumorale α Maladie inflammatoire Pathologie de l'appareil digestif Pathologie de l'intestin
- Keyword (en)
- Adalimumab Antipsoriatic agent Antirheumatic agent Chemotherapy Crohn disease Clinical trial Human Immunosuppressive agent Immunomodulator Infliximab Medicine Randomization Treatment Anti-Tumor Necrosis Factor-alpha Monoclonal antibody Anticytokine Cytokine Tumor necrosis factor α Inflammatory disease Digestive diseases Intestinal disease
- Keyword (es)
- Adalimumab Antipsoriásico Antireumático Quimioterapia Enteritis Crohn Ensayo clínico Hombre Inmunodepresor Inmunomodulador Infliximab Medicina Aleatorización Tratamiento Anti-TNF alfa Anticuerpo monoclonal Anticitoquina Citoquina Factor necrosis tumoral α Enfermedad inflamatoria Aparato digestivo patología Intestino patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B30 Public health. Hygiene-occupational medicine / 002B30A Public health. Hygiene / 002B30A11 Miscellaneous
- Discipline
- Generalities in medical sciences Public health. Hygiene-occupational medicine
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 19187100
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.7326/0003-4819-146-12-200706190-00159 
https://dx.doi.org/10.7326/0003-4819-146-12-200706190-00159
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:40:\"10.7326\/0003-4819-146-12-200706190-00159\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:114:\"Adalimumab induction therapy for crohn disease previously treated with infliximab : A randomized trial. Commentary\";s:9:\"\u0000*\u0000jtitle\";s:27:\"Annals of internal medicine\";s:9:\"\u0000*\u0000stitle\";s:16:\"Ann. intern. med\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:3:\"146\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:0:\"\";s:8:\"\u0000*\u0000epage\";s:0:\"\";s:8:\"\u0000*\u0000pages\";s:24:\"829-838, 888-890 [13 p.]\";s:7:\"\u0000*\u0000issn\";s:9:\"0003-4819\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"SANDBORN\";s:10:\"\u0000*\u0000aufirst\";s:9:\"William J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:15:\"RUTGEERTS, Paul\";i:1;s:15:\"POLLACK, Paul F\";i:2;s:13:\"MANNON, Peter\";i:3;s:12:\"ENNS, Robert\";i:4;s:18:\"HANAUER, Stephen B\";i:5;s:25:\"COLOMBEL, Jean-Fr\u00e9d\u00e9ric\";i:6;s:16:\"PANACCIONE, Remo\";i:7;s:14:\"D'HAENS, Geert\";i:8;s:5:\"JU LI\";i:9;s:18:\"ROSENFELD, Marie R\";i:10;s:15:\"KENT, Jeffrey D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AIMEAS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:114:\"Adalimumab induction therapy for crohn disease previously treated with infliximab : A randomized trial. Commentary\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:30:\"American College of Physicians\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:40:\"10.7326\/0003-4819-146-12-200706190-00159\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:114:\"Adalimumab induction therapy for crohn disease previously treated with infliximab : A randomized trial. Commentary\";s:9:\"\u0000*\u0000jtitle\";s:27:\"Annals of internal medicine\";s:9:\"\u0000*\u0000stitle\";s:16:\"Ann. intern. med\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:3:\"146\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:0:\"\";s:8:\"\u0000*\u0000epage\";s:0:\"\";s:8:\"\u0000*\u0000pages\";s:24:\"829-838, 888-890 [13 p.]\";s:7:\"\u0000*\u0000issn\";s:9:\"0003-4819\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"SANDBORN\";s:10:\"\u0000*\u0000aufirst\";s:9:\"William J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:15:\"RUTGEERTS, Paul\";i:1;s:15:\"POLLACK, Paul F\";i:2;s:13:\"MANNON, Peter\";i:3;s:12:\"ENNS, Robert\";i:4;s:18:\"HANAUER, Stephen B\";i:5;s:25:\"COLOMBEL, Jean-Fr\u00e9d\u00e9ric\";i:6;s:16:\"PANACCIONE, Remo\";i:7;s:14:\"D'HAENS, Geert\";i:8;s:5:\"JU LI\";i:9;s:18:\"ROSENFELD, Marie R\";i:10;s:15:\"KENT, Jeffrey D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AIMEAS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:114:\"Adalimumab induction therapy for crohn disease previously treated with infliximab : A randomized trial. Commentary\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:30:\"American College of Physicians\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:40:\"10.7326\/0003-4819-146-12-200706190-00159\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:40:\"10.7326\/0003-4819-146-12-200706190-00159\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:114:\"Adalimumab induction therapy for crohn disease previously treated with infliximab : A randomized trial. Commentary\";s:9:\"\u0000*\u0000jtitle\";s:27:\"Annals of internal medicine\";s:9:\"\u0000*\u0000stitle\";s:16:\"Ann. intern. med\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:3:\"146\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:0:\"\";s:8:\"\u0000*\u0000epage\";s:0:\"\";s:8:\"\u0000*\u0000pages\";s:24:\"829-838, 888-890 [13 p.]\";s:7:\"\u0000*\u0000issn\";s:9:\"0003-4819\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"SANDBORN\";s:10:\"\u0000*\u0000aufirst\";s:9:\"William J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:15:\"RUTGEERTS, Paul\";i:1;s:15:\"POLLACK, Paul F\";i:2;s:13:\"MANNON, Peter\";i:3;s:12:\"ENNS, Robert\";i:4;s:18:\"HANAUER, Stephen B\";i:5;s:25:\"COLOMBEL, Jean-Fr\u00e9d\u00e9ric\";i:6;s:16:\"PANACCIONE, Remo\";i:7;s:14:\"D'HAENS, Geert\";i:8;s:5:\"JU LI\";i:9;s:18:\"ROSENFELD, Marie R\";i:10;s:15:\"KENT, Jeffrey D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AIMEAS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:114:\"Adalimumab induction therapy for crohn disease previously treated with infliximab : A randomized trial. Commentary\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:30:\"American College of Physicians\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:40:\"10.7326\/0003-4819-146-12-200706190-00159\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:114:\"Adalimumab induction therapy for crohn disease previously treated with infliximab : A randomized trial. Commentary\";s:9:\"\u0000*\u0000jtitle\";s:27:\"Annals of internal medicine\";s:9:\"\u0000*\u0000stitle\";s:16:\"Ann. intern. med\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:3:\"146\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:0:\"\";s:8:\"\u0000*\u0000epage\";s:0:\"\";s:8:\"\u0000*\u0000pages\";s:24:\"829-838, 888-890 [13 p.]\";s:7:\"\u0000*\u0000issn\";s:9:\"0003-4819\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"SANDBORN\";s:10:\"\u0000*\u0000aufirst\";s:9:\"William J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:15:\"RUTGEERTS, Paul\";i:1;s:15:\"POLLACK, Paul F\";i:2;s:13:\"MANNON, Peter\";i:3;s:12:\"ENNS, Robert\";i:4;s:18:\"HANAUER, Stephen B\";i:5;s:25:\"COLOMBEL, Jean-Fr\u00e9d\u00e9ric\";i:6;s:16:\"PANACCIONE, Remo\";i:7;s:14:\"D'HAENS, Geert\";i:8;s:5:\"JU LI\";i:9;s:18:\"ROSENFELD, Marie R\";i:10;s:15:\"KENT, Jeffrey D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AIMEAS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:114:\"Adalimumab induction therapy for crohn disease previously treated with infliximab : A randomized trial. Commentary\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:30:\"American College of Physicians\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:40:\"10.7326\/0003-4819-146-12-200706190-00159\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:114:\"Adalimumab induction therapy for crohn disease previously treated with infliximab : A randomized trial. Commentary\";s:9:\"\u0000*\u0000jtitle\";s:27:\"Annals of internal medicine\";s:9:\"\u0000*\u0000stitle\";s:16:\"Ann. intern. med\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:3:\"146\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:0:\"\";s:8:\"\u0000*\u0000epage\";s:0:\"\";s:8:\"\u0000*\u0000pages\";s:24:\"829-838, 888-890 [13 p.]\";s:7:\"\u0000*\u0000issn\";s:9:\"0003-4819\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"SANDBORN\";s:10:\"\u0000*\u0000aufirst\";s:9:\"William J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:15:\"RUTGEERTS, Paul\";i:1;s:15:\"POLLACK, Paul F\";i:2;s:13:\"MANNON, Peter\";i:3;s:12:\"ENNS, Robert\";i:4;s:18:\"HANAUER, Stephen B\";i:5;s:25:\"COLOMBEL, Jean-Fr\u00e9d\u00e9ric\";i:6;s:16:\"PANACCIONE, Remo\";i:7;s:14:\"D'HAENS, Geert\";i:8;s:5:\"JU LI\";i:9;s:18:\"ROSENFELD, Marie R\";i:10;s:15:\"KENT, Jeffrey D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AIMEAS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:114:\"Adalimumab induction therapy for crohn disease previously treated with infliximab : A randomized trial. Commentary\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:30:\"American College of Physicians\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
